Human/Primate Cripto-1 Antibody, R&D Systems™

CRIPTO

Monoclonal

Unconjugated

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative

CFC-2, CR, Cripto-1, Cripto-1 growth factor, CRIPTOCRGF, Epidermal growth factor-like cripto protein CR1, TDGF1, TDGF-1, teratocarcinoma-derived growth factor 1

Mouse

Protein A or G purified from hybridoma culture supernatant

RUO

6997

Reconstitute at 0.5 mg/mL in sterile PBS.

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.

IgG1

Flow Cytometry, Blocking Assay, Immunocytochemistry, CyTOF, ELISA

89633

Flow Cytometry 0.25 ug/10^6 cells, Blockade of Receptor-ligand Interaction 0.1-0.5 ug/mL, Immunocytochemistry 5-25 ug/mL, CyTOF-ready, ELISA Capture (Matched Antibody Pair) 2-8 ug/mL

P13385

TDGF1

E. coli-derived recombinant human Cripto-1 Arg38-Tyr188 Accession # P13385

100 μg

Primary

Detects human and primate Cripto-1 in ELISAs. In sandwich immunoassays, no cross-reactivity with recombinant mouse Cripto-1, recombinant human (rh) EGF, rhTGF-alpha , rhTGF-beta 1, rhTGF-beta 2, rhTGF-beta 3, or rhCryptic is observed.

Human, Primate

Supernatant